QV launches first global “Skincare for Life” campaign with Those That Do, aiming to make sensitive skin mainstream

Table of Contents

1. Key Highlights:
2. Introduction
3. A 50-year heritage reframed
4. Defining the opportunity: sensitive skin as a mainstream identity
5. Creative strategy: “Skincare for Life” as emotional positioning
6. Filming, assets and a global rollout plan
7. Agency-client dynamics and production partners
8. Where QV fits in the competitive landscape
9. The consumer narrative: living “unconstrained” by skin conditions
10. Product implications: translating promises into formulations and routines
11. Measurement: how success will be judged
12. Tailoring messaging across regions and channels
13. Risks, critiques and areas to watch
14. Lessons from category peers: what has worked for other dermatology-rooted brands
15. Implementation: in-store, online and experiential tactics that will matter
16. The economics of scaling a heritage brand globally
17. What this campaign signals for consumer behavior and category trends
18. Early indicators and what to watch next
19. Industry implications: a test case for heritage brands going global
20. Voices from the launch
21. Practical guidance for consumers curious about QV’s repositioning
22. The broader narrative: why this matters beyond QV
23. FAQ

Key Highlights:

• QV has unveiled its first-ever global advertising campaign, “Skincare for Life,” created by Those That Do to reposition the 50-year-old Australian brand for mass international audiences.
• The multi-platform rollout — filmed in Dubai and running across Australia, New Zealand, the Middle East, South-East Asia and China — frames QV as an enabler of everyday confidence for people with sensitive skin.
• The campaign responds to a category shift in which a large share of consumers now self-identify as having sensitive skin, prompting established brands to balance dermatologist heritage with broader mainstream appeal.

Introduction

QV has been trusted in Australian homes and dermatology wards for five decades. Now the brand has moved beyond national recognition to the global stage with its first coordinated international advertising effort. The “Skincare for Life” campaign reframes QV’s heritage — its origin as a specialist product developed for Queen Victoria Hospital in Melbourne — into an emotional proposition that treats sensitive-skin care not as a clinical afterthought but as a daily enabler of confidence. Designed by Those That Do and filmed in Dubai, the campaign runs across television, out-of-home, point-of-sale, social and digital channels across multiple regions. This launch marks a strategic pivot: defending QV’s dermatologist-trusted credentials while broadening its appeal to millions who now consider themselves sensitive-skin sufferers.

A 50-year heritage reframed

QV’s origins are pragmatic and clinical. The product line began when Australian chemist Gerald Oppenheim was asked to create a specialist skin formulation for the dermatology ward at Melbourne’s Queen Victoria Hospital. The original QV Bath Oil carried the hospital’s initials and a clear association with clinical care. Over five decades that association became a core asset: QV earned trust among clinicians and consumers for gentle, straightforward formulations aimed at dry and sensitive skin.

That clinical credibility has been a double-edged sword. It granted QV authority but also risked confining the brand to a medical or niche category while competitors marketed themselves as lifestyle brands with mass appeal. The “Skincare for Life” campaign reframes the brand’s origin story. It keeps the dermatologist-trusted heritage at the center while translating clinical efficacy into everyday benefits: fewer interruptions from flare-ups, greater freedom to enjoy ordinary moments and consistent confidence in daily life. This reframing shifts QV from a reactive solution for acute skin issues to a proactive partner in routine wellbeing.

Heritage brands frequently face this decision point: enhance the clinical story to preserve trust or broaden the narrative to capture lifestyle-oriented buyers. QV’s strategy threads both needles, retaining the clinical cue as credibility while foregrounding lived experience—simple scenes of daily life that resonate emotionally rather than clinically.

Defining the opportunity: sensitive skin as a mainstream identity

Ben Walker, founder and director of Those That Do, highlights a clear marketplace shift: nearly two-thirds of people now identify as having some form of skin sensitivity. That observation aligns with broader trends the industry has experienced over the last decade. Consumers are increasingly self-diagnosing conditions such as sensitivity, dryness, redness and barrier dysfunction and are seeking accessible solutions beyond prescription or clinic-only channels. Grocery-store aisles once dominated by general moisturizers now feature explicit “for sensitive skin” callouts. New entrants and established mass and prestige players alike have expanded into this space.

That movement altered competitive dynamics. Once the preserve of medical dermatology brands, sensitive-skin positioning is now contested territory. Brands that historically relied on dermatologist endorsement — La Roche-Posay, Eucerin and CeraVe among them — have broadened distribution and invested heavily in consumer education and lifestyle marketing. Newer brands emphasize clean ingredients and sensory appeal alongside claims of gentleness. Retailers have responded by creating dedicated sensitive-skin ranges and shelf-blocks, and online marketplaces flag sensitivity-friendly formulations as key search filters.

For QV, this is both a threat and an opportunity. The brand’s dermatological legacy is valuable in a market where trust matters, but the category’s expansion means QV must compete with brands that pair clinical claims with modern storytelling and omnichannel reach. “Skincare for Life” addresses that by preserving QV’s trusted identity while translating it into an emotional benefit that speaks to millions who want to live “unconstrained” by skin conditions.

Creative strategy: “Skincare for Life” as emotional positioning

The campaign premise is straightforward: when sensitive skin is controlled, people live better — more confident, freer and less preoccupied. The creative avoids medical dramatization. Instead it uses imagery and short narratives of everyday human moments enabled by effective skincare. Scenes portray small but universally relatable experiences: a parent confidently lifting an infant, a person applying makeup without hesitation, friends embracing, a runner enjoying an evening jog. Each moment communicates an absence of disruption — the subtle, powerful idea that good skincare removes friction from life rather than dominating it.

That strategic move is notable for its emotional economy. Medical-language claims often focus on symptoms, ingredients and clinical trials. These are vital to building credibility but rarely translate into immediate emotional appeal. QV’s campaign prioritizes the emotional end state, positioning the product not merely as a treatment but as an enabler. The tagline “Skincare for Life” performs double duty: it references the product’s suitability for lifelong daily use and foregrounds life-enhancement as the principal promise.

Visual and tonal choices also align with the repositioning. Filming in Dubai offered a modern, cosmopolitan setting that can read as international rather than region-specific, and the campaign’s production values were tailored to produce imagery suitable for diverse markets and formats — high-definition television, out-of-home billboards, point-of-sale materials and platform-native social and digital content.

Filming, assets and a global rollout plan

Production took place in Dubai, a location chosen for its visual versatility, architectural breadth and logistical infrastructure capable of supporting an international shoot. Dubai provides backdrops that read as contemporary and cosmopolitan: sunlit streets, intimate interiors and crowd scenes that suggest modern life across cultures without anchoring the creative in any single national identity.

The campaign’s assets are built for modular deployment. Core cinematic spots supply brand-level storytelling for television and long-form social distribution. Short-form spots and cutdowns feed platforms with constrained runtimes—optimal for social feeds and outdoor digital displays. Point-of-sale assets translate the same moments into shelf-facing messaging, while out-of-home treatments use evocative imagery and concise text to maintain high-impact visibility. This multi-format strategy reflects standard global-campaign practice: create a central creative island and adapt it for each channel’s consumption habits.

The rollout covers Australia and New Zealand, the Middle East, South-East Asia and China. Those markets differ culturally and in media consumption patterns. For example, China’s digital ecosystem favors Douyin, WeChat and e-commerce platforms where short video, influencer partnerships and livestreaming strongly influence purchase decisions. Southeast Asian markets emphasize mobile-first engagement and strong retail partnerships. The Middle East combines traditional broadcast and rapidly growing digital media consumption, while Australia and New Zealand represent QV’s home market and a key base for brand equity. The campaign’s modularity allows messaging to be tailored without losing the central “Skincare for Life” narrative.

Agency-client dynamics and production partners

Those That Do, a global full-service creative agency, led concept and creative execution through its Sydney team. The agency has worked with QV since 2022, giving it a contemporary understanding of the brand and an established working relationship with the client, Ego Pharmaceuticals. In creative partnerships that stretch across brand heritage and global ambitions, this continuity matters. Longstanding agency-client relations afford deeper access to brand history, product know-how and often more candid internal alignment on strategic priorities.

Production company electriclime handled the shoot. The decision to partner with a production house that can execute cross-format work is typical for campaigns requiring a mix of cinematic and digitally optimized assets. The production’s international footprint, logistics and the ability to craft culturally neutral yet emotionally resonant visuals were likely key selection criteria.

Simone Thomassen, QV’s Global Marketing Manager, framed the campaign as both a defense and an expansion of brand purpose. She stressed that the creative positions QV “not just as a solution, but as an enabler, allowing our customers to confidently step into every moment of their lives, every single day.” That language clarifies the difference between a purely functional positioning and one that elevates the brand into the everyday psyche of the consumer.

Where QV fits in the competitive landscape

The global sensitive-skin category now includes legacy dermatology brands, omnichannel mass-market players and digitally native startups. Each competes on a combination of trust signals (clinical endorsements, ingredient lists), sensory experience (texture, scent) and convenience (price, availability). QV’s competitive advantage remains its clinical provenance, but the brand must now match the category’s modern competencies: streamlined e-commerce, influencer and content strategies, multilingual and culturally adapted advertising, and clear shelf differentiation.

Comparable brand trajectories help frame what QV is attempting. CeraVe is one example of a brand that scaled from dermatologist endorsement to mass-market ubiquity by emphasizing barrier repair, simple ingredient lists and accessible price points. La Roche-Posay has balanced dermatologist partnerships with a lifestyle-friendly brand voice and extensive clinical research to back claims. Eucerin has similarly maintained clinical credibility while expanding into mainstream distribution. These cases demonstrate that heritage clinical brands can expand successfully when they modernize communication styles and distribution while protecting the clinical core.

QV’s approach reflects a similar playbook: preserve the trust cues while making the emotional payoff central. The risk for any heritage brand is either diluting medical credibility in pursuit of broader appeal or failing to grow because the storytelling remains too clinical for mainstream buyers. “Skincare for Life” directly navigates that tension by foregrounding daily life outcomes while maintaining the implicit trust in the product’s origins.

The consumer narrative: living “unconstrained” by skin conditions

The campaign’s central consumer promise is liberation from the constant vigilance that living with sensitive skin often requires. For many, sensitive skin means ritualized avoidance: certain fabrics, climates, foods, and cosmetics become potential triggers. That burden affects choices large and small: whether to attend social events, try new makeup, exercise outdoors or simply sleep on certain bedding.

By playing to everyday scenes rather than medical indicators, QV reframes the consumer narrative. The brand does not need to convince consumers it reduces redness or improves barrier function on a cellular level; instead it needs to show outcomes people care about. If a product enables someone to hug a friend without concern for irritation or apply lipstick with confidence, that message is directly relevant to purchase behavior.

This strategy also taps into identity: people increasingly choose brands that reflect how they want to feel, not merely what their condition is called. A brand that promises reliable daily performance and positions itself as a partner in life experiences becomes part of aspirational self-expression. For QV, that means moving beyond “for sensitive skin” as a purely functional label and toward a lifestyle proposition: QV supports your life.

Product implications: translating promises into formulations and routines

Positioning alone will not hold without product performance that justifies the emotional promise. QV’s product range — including its original Bath Oil and a suite of moisturizers and cleansers — must deliver consistent tolerability and measurable improvements in skin comfort for everyday users. The formulations historically emphasize low-irritant ingredients, absence of common allergens or fragrances, and textures that suit sensitive skin’s variable needs.

For the campaign to convert attention into purchase, packaging, product education, and in-store experience must align. Point-of-sale materials need to explain what makes QV suitable for daily life: ingredient simplicity, non-comedogenic formulas, pH balance and dermatological testing. E-commerce pages should provide quick education through FAQs, before-and-after imagery, and testimonials. Sampling programs, pharmacy endorsements and clinician-facing materials can reinforce trust for consumers who still seek assurance from health professionals.

Routine proposals should be practical. Sensitive-skin consumers often respond well to simple, repeatable regimens with few steps and clear reasoning: gentle cleanser, barrier-repair moisturizer, and targeted treatments for flare-ups. Marketing that communicates how QV fits into these routines—quick morning steps, night-time recovery rituals, or post-swim hydration—will likely be more effective than intricate multi-step regimes that overwhelm time-pressed consumers.

Measurement: how success will be judged

Campaign performance will be judged across several domains. Brand-level metrics—awareness, consideration and preference—will be critical, especially in markets where QV is newly introduced. Conversion metrics will include in-store sales increases, e-commerce traffic and conversion rates, average order value and repeat purchase rates. Digital metrics such as view-through rate, social engagement, share of voice and paid media efficiency will also figure prominently.

A sophisticated global campaign will layer short-term activation metrics with longer-term brand health measures. Immediate ROI from TV and OOH may be hard to credit directly to sales without a strong omnichannel measurement framework that ties TV exposure to digital search lift and subsequent purchase. Attribution models that combine first-party sales data with media exposure will be key for Ego Pharmaceuticals to evaluate the campaign’s effectiveness and to plan follow-up marketing investments.

For clinically positioned brands, clinical endpoints and professional endorsements offer additional success signals. Increased pharmacy recommendations, clinician awareness and inclusion in dermatology guidelines or professional formularies are slower-moving but valuable measures that can sustain market position beyond initial advertising bursts.

Tailoring messaging across regions and channels

Global campaigns succeed when they strike a balance between a unified brand core and localized relevance. QV’s creative island — everyday enabled moments — provides a platform that can be adapted to reflect cultural nuances and media habits.

China requires distinctive execution. Short video content optimized for Douyin, KOL partnerships and livestream commerce integrations will drive reach and conversion. Messaging should consider consumer priorities in the market: ingredient transparency, perceived efficacy and recommendations from trusted local figures. Social commerce bundles, limited-time offers and localized packaging can accelerate trial.

Southeast Asia’s diversity suggests differentiated strategies across countries. Tropical climates influence product preferences — lighter, fast-absorbing moisturizers or formulations with UV-considerations may be more relevant. Market access via e-commerce platforms such as Shopee and Lazada should be combined with brick-and-mortar pharmacy relationships where trust-driven categories still favor in-person consultation.

The Middle East combines modern retail and traditional pharmacy channels. Messaging that addresses climate-related skin sensitivity—dryness from air conditioning or irritation from sun exposure—will resonate. Out-of-home and broadcast may retain effective reach in certain demographics, complemented by digital activations.

Australia and New Zealand represent both origin story and a testbed. Here, QV’s heritage has recognition; the campaign’s performance domestically will validate creative assumptions and provide learning for rollouts elsewhere.

Risks, critiques and areas to watch

Any repositioning carries risks. The primary risk is authenticity dilution. If consumers perceive the campaign as glossing over the science behind product claims in favor of lifestyle imagery, trust could erode. Maintaining visible signals of clinical credibility—clear ingredient communication, dermatologist references and accessible research—will be crucial to offset that risk.

Another risk is category commoditization. As more brands claim “sensitive skin” credentials, differentiation can become harder. QV must translate its history into distinct, demonstrable benefits rather than relying solely on nostalgia or name recognition.

Regulatory and claim-compliance challenges are also present in global rollouts. Countries vary in permitted health claims, labeling requirements and advertising standards for medical or quasi-medical products. The campaign’s messaging and on-pack copy must be adapted to local regulations to avoid legal friction or forced retractions.

Finally, global campaigns can underperform if local execution trumps global coherence. Local teams must have the latitude to adapt while preserving the brand’s central promise. The executional balance between global templates and local nuance will determine both short-term conversion and long-term brand equity.

Lessons from category peers: what has worked for other dermatology-rooted brands

Other heritage brands offer instructive case studies. CeraVe’s expansion strategy combined credible clinical messaging (barrier repair, ceramide content) with mass distribution and pricing accessibility. The brand prioritized dermatologist recommendations, while simultaneously optimizing formulation simplicity and social content that educates customers on barrier science.

La Roche-Posay emphasized professional endorsements and clinical trials to support claims such as sunscreen performance and tolerability for reactive skin. The brand invested heavily in dermatology partnerships and educational initiatives that built trust among both clinicians and consumers.

These examples show that a hybrid approach—clinical rigor plus modern marketing—is effective. QV’s pathway mirrors these strategies: keep the clinical story evident, use authoritative cues, and package them in emotionally resonant creative that speaks to everyday life.

Implementation: in-store, online and experiential tactics that will matter

The campaign’s translation to point-of-sale is critical. Physical retail still dominates certain categories and demographics. Shelf-blocking, clear in-store educational panels, and pharmacist-endorsed signage will drive trial among shoppers seeking reassurance. Samples and travel-size packs near checkouts can convert hesitant buyers.

Online, product pages must be optimized for conversion. Clear hero messages that articulate immediate benefits, ingredient callouts that resonate with sensitivity-minded shoppers (fragrance-free, hypoallergenic, pH-balanced), video testimonials, and instructional content will reduce friction. Bundles and subscription offers encourage repeat purchase and lifetime value.

Experiential marketing—pop-up skin barrier checks, partnerships with clinics, or co-branded health events—can translate mass messaging into tactile trust-building encounters. These activations help bridge the experiential gap between clinical credibility and lifestyle marketing.

Influencer partnerships require careful curation. For sensitive skin, authentic voices with personal skin stories or professionals (dermatologists, pharmacists) can provide both emotional resonance and credibility. Micro-influencers with engaged, niche followings can yield higher trust for specific demographics.

The economics of scaling a heritage brand globally

Global expansion requires investment in media, distribution and operational channels. For brands like QV, initial media spending buys awareness; follow-through investments in local supply chains, retailer partnerships and regulatory compliance sustain availability. Pricing strategy must align across markets—premium positioning in some territories and accessible mass-market pricing in others can create brand confusion if not managed carefully.

Margins and promotional cadence also need calibration. Overreliance on discounting to drive trial can undermine perceived value. A promotion-led launch might accelerate sampling but risks positioning QV as a deal-driven brand rather than a trusted, everyday essential.

Ego Pharmaceuticals, as QV’s parent, will likely monitor market-by-market performance and adjust investment accordingly. The first global campaign serves as both a brand moment and a data collection exercise to refine investment allocation—identify which markets respond best, which channels drive incremental growth, and where product adaptations are required.

What this campaign signals for consumer behavior and category trends

The launch confirms a broader industry movement: sensitive-skin care is no longer marginalized. Consumers treat skin sensitivity as a lifestyle attribute requiring daily management rather than a medical anomaly. Brands that recognize this shift and position their products as partners in everyday confidence will capture both emotional loyalty and functional repeat purchase.

The campaign also reflects how heritage brands are adapting. Trust and clinical origin are no longer enough; brands must pair evidence with storytelling that reflects lived experience. Success will hinge on delivering consistent product performance that aligns with the emotional promise.

Expect to see more legacy brands adopt similar playbooks: translate clinical credibility into lifestyle propositions, invest in omnichannel production, optimize for local market nuances and engage with consumers using trusted voices across digital and offline channels.

Early indicators and what to watch next

Short-term indicators will include share-of-voice gains in advertising markets, uplift in search and brand-related social conversations, initial sales spikes in markets exposed to TV and OOH, and engagement levels on social video content. Watch for the following:

• Repeat purchase rates. A strong indicator that the product works as promised and that brand messaging aligns with lived experience.
• Clinician endorsements and pharmacy recommendations. Sustained professional support signals the brand hasn’t sacrificed medical credibility.
• Local market adaptations. How QV tailors formulations, packaging or bundles for climate and cultural differences will determine longer-term regional penetration.
• Digital conversion efficiency. The ability to turn earned and paid media into measurable online sales in key e-commerce hubs, especially China and Southeast Asia.

If QV secures balance on these fronts, the campaign will be judged a strategic success that modernizes the brand while preserving the trust that built it.

Industry implications: a test case for heritage brands going global

QV’s campaign will be watched closely by peers. It functions as a test case for whether a clinically rooted, historically domestic brand can scale globally without losing its core promise. If successful, it will provide a replicable blueprint: marry heritage credibility with emotionally resonant storytelling, design assets for modular global deployment, and tie creative to measurable product outcomes and distribution strategies.

Two broader industry implications stand out. First, the mainstreaming of sensitive-skin care will drive more product innovation around barrier support, ultra-gentle actives and microbiome-friendly formulations. Second, marketing that positions skincare as an enabler of everyday experiences will likely proliferate, pushing clinical brands to rethink creative strategies and measurement frameworks.

Voices from the launch

Those That Do’s Ben Walker framed the campaign as a necessary evolution: having worked with QV for many years, the agency recognized the brand’s association with sensitive-skin care and the need to translate that legacy into broader consumer appeal. Walker emphasized the emotional impact of sensitivity and the opportunity to position QV as a brand that allows consumers to live more confidently.

Simone Thomassen, QV’s Global Marketing Manager, highlighted the campaign’s dual nature: honoring more than 50 years of dermatologist-trusted heritage while meeting contemporary consumer needs. Her description of QV as an “enabler” captures the campaign’s central ambition — to be part of daily life rather than a last-resort solution.

Their shared emphasis on empathy — understanding how sensitive skin affects day-to-day life — informs the execution. The creative moves away from clinical testimony and toward human moments, signaling a strategic choice about what will motivate modern consumers.

Practical guidance for consumers curious about QV’s repositioning

Consumers who live with sensitive skin and are encountering QV’s new campaign should consider a few practical steps:

• Read product labels. Look for fragrance-free, low-irritant formulations and simple ingredient lists. QV’s longstanding formulations typically prioritize these features.
• Trial with purpose. Use small sizes or samples to test tolerability over several days before committing to a full-size product.
• Think routine. Incorporate QV products into an uncomplicated daily regimen: gentle cleanse, hydrate with an appropriate moisturizer, and protect skin from environmental stressors when needed.
• Consult trusted professionals. If symptoms persist or worsen, seek advice from a dermatologist. Brands like QV are designed for everyday use but do not replace personalized medical care when required.

These steps help consumers translate the campaign’s promise into real-world outcomes.

The broader narrative: why this matters beyond QV

This campaign matters because it highlights how established healthcare-rooted consumer brands evolve when the market expands. QV’s move is evidence that clinically oriented brands must translate technical efficacy into emotional utility to remain relevant as categories mature. Commercial success will depend not only on the creative but on product performance, distribution execution, and the ability to measure and iterate across diverse markets.

For marketers, QV’s launch provides a practical example of balancing heritage and modernity. For consumers, it promises greater visibility and potentially more accessible solutions for sensitive skin. For industry observers, it is a reminder that product categories shift and that brands must adapt without losing the elements that made them trusted in the first place.

FAQ

Q: What is the main message of the QV “Skincare for Life” campaign? A: The campaign positions QV as a daily enabler: effective, gentle skincare that lets people live confidently without being constrained by sensitive skin. It shifts the conversation from treating symptoms to enabling everyday life.

Q: Where will the campaign run? A: The campaign will run across Australia, New Zealand, the Middle East, South-East Asia and China, using television, social, out-of-home, point-of-sale and digital channels.

Q: Why did QV choose to reposition now? A: The market has shifted as a larger share of consumers self-identify as having sensitive skin. This expansion has attracted new competitors and encouraged legacy brands to broaden messaging to capture mainstream consumers while retaining clinical credibility.

Q: Who created and produced the campaign? A: The creative was developed by Those That Do, with production by electriclime. QV’s owner, Ego Pharmaceuticals, is the client overseeing the launch.

Q: How does this campaign keep QV’s clinical credibility intact? A: While the creative emphasizes emotional outcomes, QV retains its clinical signals — brand history, formulation simplicity and dermatologist-trusted heritage — and these remain evident through product information, packaging and professional endorsements.

Q: Will QV change its formulations to appeal to new markets? A: The campaign centers on messaging rather than product reformulation. However, market-specific preferences (lighter textures for humid climates, packaging sizes for e-commerce) may lead to tactical adjustments in select regions.

Q: How can consumers evaluate whether QV products will work for their sensitive skin? A: Consumers should check ingredient lists for fragrance and irritant avoidance, try sample sizes to assess tolerability, and consult dermatologists when needed. QV’s historical focus has been on low-irritant, gentle formulations suitable for sensitive skin.

Q: What metrics will determine the campaign’s success? A: Key measures include brand awareness, consideration, sales lift, repeat purchase rates, digital engagement, and professional endorsement or pharmacy recommendation rates. Market-specific adoption and conversion metrics will also be important.

Q: Could this repositioning dilute QV’s dermatologist reputation? A: Dilution is a risk if storytelling replaces evidence. QV’s strategy aims to avoid that by keeping clinical heritage visible while adding emotional resonance. Sustained product performance and clear communication will be key to maintaining trust.

Q: What should other heritage brands learn from this launch? A: Heritage brands should balance authority and modernity by preserving trust signals while adopting emotionally relevant storytelling and flexible asset strategies that allow local adaptation for global markets.